Vipragen Biosciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 17-06-2024
- Paid Up Capital ₹ 7.92 Cr
as on 17-06-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.26 Cr
as on 17-06-2024
- Revenue 1.77%
(FY 2023)
- Profit -796.89%
(FY 2023)
- Ebitda -60.36%
(FY 2023)
- Net Worth -11.57%
(FY 2023)
- Total Assets 11.26%
(FY 2023)
About Vipragen Biosciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.92 Cr.
The company currently has active open charges totaling ₹7.26 Cr.
Kannasandra Pushpalatha, Pallavur Harikrishnan, Yashas, and Three other members serve as directors at the Company.
- CIN/LLPIN
U73100KA2012PTC063955
- Company No.
063955
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Mysore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vipragen Biosciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddamadappa Chandrashekaran  | Managing Director | 05-Oct-2015 | Current |
| Chaitra Harsha | Managing Director | 14-Oct-2016 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Umesh Devurkar | Director | 17-Sep-2012 | Current |
| Kannasandra Pushpalatha | Director | 01-Jul-2014 | Current |
| Pallavur Harikrishnan | Nominee Director | 03-Oct-2023 | Current |
| Yashas | Director | 10-Feb-2021 | Current |
Financial Performance and Corporate Structure Insights of Vipragen Biosciences.
Vipragen Biosciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.77% increase. The company also saw a substantial fall in profitability, with a 796.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vipragen Biosciences?
In 2023, Vipragen Biosciences had a promoter holding of 37.95% and a public holding of 62.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Karnataka Asset Management Company Private LimitedActive 26 years 7 monthsPallavur Harikrishnan is a mutual person
Karnataka Trustee Company Private LimitedActive 26 years 7 monthsPallavur Harikrishnan is a mutual person
Cypa Therapeutics Private LimitedActive 2 years 6 monthsKannasandra Pushpalatha and Yashas are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 May 2022 | ₹9.10 M | Open |
State Bank Of Mysore Creation Date: 19 Jan 2016 | ₹2.70 Cr | Open |
State Bank Of India Creation Date: 27 Sep 2013 | ₹3.65 Cr | Open |
How Many Employees Work at Vipragen Biosciences?
Vipragen Biosciences has a workforce of 75 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vipragen Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vipragen Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
